111 Price to Sales Ratio 2018-2025 | YI
Historical PS ratio values for 111 (YI) over the last 10 years. The current P/S ratio for 111 as of November 14, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| 111 P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-11-14 | 4.08 | 0.02 | |
| 2025-06-30 | 7.14 | $225.62 | 0.03 |
| 2025-03-31 | 8.11 | $229.04 | 0.04 |
| 2024-12-31 | 6.23 | $229.93 | 0.03 |
| 2024-09-30 | 7.56 | $241.16 | 0.03 |
| 2024-06-30 | 10.65 | $240.89 | 0.04 |
| 2024-03-31 | 11.60 | $242.97 | 0.05 |
| 2023-12-31 | 15.50 | $250.23 | 0.06 |
| 2023-09-30 | 26.00 | $248.64 | 0.10 |
| 2023-06-30 | 24.60 | $245.69 | 0.10 |
| 2023-03-31 | 26.50 | $243.07 | 0.11 |
| 2022-12-31 | 30.20 | $235.30 | 0.13 |
| 2022-09-30 | 26.80 | $235.75 | 0.11 |
| 2022-06-30 | 20.60 | $241.86 | 0.09 |
| 2022-03-31 | 26.60 | $243.92 | 0.11 |
| 2021-12-31 | 35.00 | $235.18 | 0.15 |
| 2021-09-30 | 61.70 | $222.39 | 0.28 |
| 2021-06-30 | 90.85 | $202.02 | 0.45 |
| 2021-03-31 | 138.00 | $173.39 | 0.80 |
| 2020-12-31 | 69.50 | $152.64 | 0.46 |
| 2020-09-30 | 62.00 | $120.68 | 0.51 |
| 2020-06-30 | 63.50 | $97.40 | 0.65 |
| 2020-03-31 | 66.10 | $84.45 | 0.78 |
| 2019-12-31 | 67.30 | $69.33 | 0.97 |
| 2019-09-30 | 48.70 | $61.90 | 0.79 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.035B | $1.973B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.084B | 58.67 |
| Tempus AI (TEM) | United States | $11.897B | 0.00 |
| Doximity (DOCS) | United States | $9.342B | 38.47 |
| Hims & Hers Health (HIMS) | United States | $8.418B | 68.48 |
| IRhythm Technologies (IRTC) | United States | $5.504B | 0.00 |
| Hinge Health (HNGE) | United States | $3.224B | 0.00 |
| Privia Health (PRVA) | United States | $2.884B | 180.38 |
| Inspire Medical Systems (INSP) | United States | $2.509B | 41.51 |
| Heartflow (HTFL) | United States | $2.383B | 0.00 |
| 10x Genomics (TXG) | United States | $1.978B | 0.00 |
| Enovis (ENOV) | United States | $1.715B | 9.01 |
| Omnicell (OMCL) | United States | $1.576B | 32.22 |
| Azenta (AZTA) | United States | $1.364B | 59.50 |
| Phreesia (PHR) | United States | $1.304B | 0.00 |
| Schrodinger (SDGR) | United States | $1.299B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.276B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.900B | 0.00 |
| Claritev (CTEV) | United States | $0.715B | 0.00 |
| Talkspace (TALK) | United States | $0.538B | 108.33 |
| Butterfly Network (BFLY) | United States | $0.536B | 0.00 |
| Veradigm (MDRX) | United States | $0.523B | 0.00 |
| Standard BioTools (LAB) | United States | $0.477B | 0.00 |
| Evolent Health (EVH) | United States | $0.466B | 0.00 |
| Carlsmed (CARL) | United States | $0.349B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.348B | 0.00 |
| TruBridge (TBRG) | United States | $0.306B | 14.05 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.239B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.212B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.200B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.172B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.170B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.160B | 0.00 |
| CareCloud (CCLD) | United States | $0.133B | 7.28 |
| EUDA Health Holdings (EUDA) | Singapore | $0.110B | 0.00 |
| Outset Medical (OM) | United States | $0.085B | 0.00 |
| American Well (AMWL) | United States | $0.066B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.066B | 0.00 |
| Pulmonx (LUNG) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.049B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Precipio (PRPO) | United States | $0.031B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.025B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.012B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |